Company news
Exagen Inc. news in 2020
Exagen Inc.'s news releases, calls and decks from 2020, newest first.
Exagen Inc. Reports Third Quarter 2020 Results
November 9, 2020
Exagen Inc. Announces Study to Evaluate Emergence of Autoimmune Diseases After COVID-19 Infection
November 1, 2020
Exagen to Announce Third Quarter Financial Results on November 10, 2020
October 26, 2020
Exagen Inc. Announces Agreement with Provider Network of America Expanding Access for AVISE® Tests to 8 Million Members
September 28, 2020
Exagen Appoints Wendy Johnson to Board of Directors
September 22, 2020
Exagen Launches Test to Aid in the Detection of ANCA-Associated Vasculitis (AAV)
September 20, 2020
Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid Syndrome
August 2, 2020
Exagen Inc. Reports Second Quarter 2020 Results
July 27, 2020
Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East
July 26, 2020
Exagen to Announce Second Quarter Financial Results on July 28, 2020
July 15, 2020
Exagen and the Ohio State Innovation Foundation Announce Exclusive License Agreement and Research Collaboration for a Novel, Rule-In, Blood Test to Support the Diagnosis of Fibromyalgia
June 16, 2020
Exagen Inc. Announces Clinical Trial Conducted at Major Academic Center in Distinguishing Type 1 and Type 2 Lupus
June 2, 2020
Exagen Inc. Reports First Quarter 2020 Results
May 10, 2020
Exagen to Announce First Quarter Financial Results on May 11, 2020
April 26, 2020
Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results
March 24, 2020
Exagen Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer, and Anja Kammesheidt, Ph.D., as Chief Scientific Officer
March 23, 2020
Exagen Inc. Partners with Sonora Quest Laboratories to Offer AVISE Testing for Patients Suspected of Autoimmune Disease
March 15, 2020
Exagen to Announce Fourth Quarter and Year-End 2019 Financial Results on March 25, 2020
March 10, 2020